Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles UMass Tops Endowment Performance Rankings for 2025 Michelle Celarier Mercer to Benchmark Private Market Performance Amid Marsh Rebrand James Comtois Portfolio Finance: 101 Sponsored by Barings